2018 NYC. Viral Hepatitis Research Symposium

Size: px
Start display at page:

Download "2018 NYC. Viral Hepatitis Research Symposium"

Transcription

1

2 Implementation and Evaluation of a Care Coordination Intervention for Patients with HCV Following Release from the New York City Jails Matthew Akiyama, MD, MSc Montefiore Medical Center / Albert Einstein College of Medicine

3 Disclosures Gilead Investigator Sponsored Research Grant

4 Outline Introduction HCV in correctional settings Linkage to HCV care following release from jail Conclusions/Future directions

5 HCV in Corrections Detainees bear disproportionate burden of HCV Interrelationship between high risk behaviors and incarceration National prevalence 17% Varan AK et al Public Health Rep.

6 HCV in Jail Short lengths of stay High volumes of detainees pass through US jails 1/3 of incarcerated adults 731,000 at any given time 12 million admissions per year 19 times the number in state and federal prisons Opportunity to provide HCV screening and linkage to care Kaeble et al. Bureau of Justice Statistics

7 Linkage to HCV Care Few existing data Rhode Island, 1 North Carolina/South Carolina 2 Variety of components have been used Informational video, posttest counseling, referral to community care, appointment scheduling 17%-56% linked to HCV care after release 1. Beckwith CG et al Schoenbachler BT et al. 2016

8 Objectives To assess the impact of a transitional care coordination intervention on linkage to HCV care To determine barriers to and facilitators of linkage to HCV care

9 New York City Jail System 10 facilities on Rikers Island 4 borough facilities Average daily population of ~10,000 More than 60,000 admissions per year Existing HIV transitional care coordination program No specific program for HCV

10 Methods One armed clinical trial Enrolment 5/2015-4/2017 Inclusion criteria: 18 years old Chronic HCV infection Anticipated release date permitting follow up within study period Exclusion criteria: Unable or unwilling to sign consent Anticipated transfer to prison HIV-infection

11 Methods Care Coordination Intervention Needs assessment HCV education D/c planning by jail-based transitional care coordinator Appointment scheduling (target within 2 weeks of release) Study coordinator contact number Jail Reminder calls Appointment accompaniment Community

12 Methods Primary outcome: Linkage to HCV care within 180 days of release Secondary outcomes: HCV treatment initiation HCV treatment completion SVR

13 Methods Predictors of linkage using the Addiction Severity Index at enrolment Employment, drug/alcohol use, legal status, family/social support, mental health Statistical significance was determined using Chi-square / Fisher s exact tests (p<0.05) EventFlow - visually inspect data and identify relevant temporal event sequences

14 Study Flow Chart 185 Approached for Eligibility 21 Ineligible 13 Pending transfer or sentence > 1 yr 5 Already on HCV Tx 2 Unable to give consent 1 HCV RNA negative 105 Enrolled 100 Followed 5 Excluded (HIV+) 8 Transferred to prison or other jurisdiction 4 Remained in jail 2 HCV Tx pre-release 1 HCV VL cleared 1 Died pre-release 59 Refused 24 Interested in HCV Tx, not in study (alternative provider specified) 8 Interested in HCV Tx, not in study (no alternative provider specified) 5 Not currently interested in HCV Tx 4 Time constraint 1 Will be treated in jail 17 Did not specify 84 Released from index incarceration

15 Results Mean duration of time between enrollment and release was 71 days (SD=101) Participant contacts attempted 3.8 (SD=4.4) 42 (50%) participants successfully contacted Participant NOK contacts attempted 2.7 (SD=2.1) 53 (63%) participants NOK successfully contacted

16 Results Primary Outcome: 26/84 (31%) participants linked to HCV care (median of 20 days) 17 (20%) initiated HCV treatment 15 (18%) completed treatment 7 (8%) out of 9 (78%) w/ 12 week follow-up had SVR

17 Correctional-community continuum of care 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 84% 33% 31% 20% 18% *78% w/ 12 wk f/u * 8% Total Released Reincarcerated Linked Tx Initiation Tx Complete SVR

18 Correctional-community continuum of care 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 84% Intervention? 33% 31% 20% 18% *78% w/ 12 wk f/u * 8% Total Released Reincarcerated Linked Tx Initiation Tx Complete SVR

19 Correctional-community continuum of care 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 84% Intervention? 33% 31% Retention? 20% 18% *78% w/ 12 wk f/u * 8% Total Released Reincarcerated Linked Tx Initiation Tx Complete SVR

20 Participant # Event Flow Plot 33% were reincarcerated within 180 days Reincarceration and linkage equally common initial event (23 participants) 3 participants were linked to care following reincarceration No association between reincarceration within 180 days and linkage to care (p = 0.86) Days

21 Cohort Characteristics Total N = 84 (%) Linked to care N=26 (%) Unlinked to care N=58 (%) Age, mean (SD) 44 (13) 47 (11) 44 (12) 0.29 Female Male Race/ethnicity Hispanic NH Black NH White Other 36 (43) 48 (57) 46 (54) 15 (18) 19 (23) 4 (5) 9 (35) 17 (65) 15 (58) 5 (19) 5 (19) 1 (4) 27 (47) 31 (53) 31 (53) 10 (18) 14 (25) 3 (5) Homeless 22 (27) 5 (19) 17 (30) 0.11 Graduated high school 48 (57) 14 (54) 34 (59) 0.62 Mental illness 53 (63) 13 (50) 40 (69) 0.10 Ever injected 51 (61) 16 (62) 35 (60) 0.92 On methadone 53 (64) 20 (77) 33 (58) 0.03 Feel supported socially 69 (83) 25 (96) 44 (77) 0.03 Alcohol to intoxication 31 (37) 5 (19) 26 (45) 0.02 Primary care provider 19 (23) 9 (38) 10 (18) 0.06 Based on self-report regarding the pre-incarceration period P value

22 Cohort Characteristics Total N = 84 (%) Linked to care N=26 (%) Unlinked to care N=58 (%) Age, mean (SD) 44 (13) 47 (11) 44 (12) 0.29 Female Male Race/ethnicity Hispanic NH Black NH White Other 36 (43) 48 (57) 46 (54) 15 (18) 19 (23) 4 (5) 9 (35) 17 (65) 15 (58) 5 (19) 5 (19) 1 (4) 27 (47) 31 (53) 31 (53) 10 (18) 14 (25) 3 (5) Homeless 22 (27) 5 (19) 17 (30) 0.11 Graduated high school 48 (57) 14 (54) 34 (59) 0.62 Mental illness 53 (63) 13 (50) 40 (69) 0.10 Ever injected 51 (61) 16 (62) 35 (60) 0.92 On methadone 53 (64) 20 (77) 33 (58) 0.03 Feel supported socially 69 (83) 25 (96) 45 (78) 0.02 Alcohol to intoxication 31 (37) 5 (19) 26 (45) 0.02 Primary care provider 19 (23) 9 (38) 10 (18) 0.06 Based on self-report regarding the pre-incarceration period P value

23 Conclusions Integrated jail and community-based care coordination program may be effective in improving timely linkage to HCV care Significant barriers remain Multicomponent intervention aimed increasing social support, linkage to substance use treatment (OAT / alcohol), and primary care Reincarceration - opportunity to reengage individuals who have not yet linked to HCV care

24 Future Directions: HCV-ACCELERATE The HCV-ACCELERATE Trial Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional re-entrants Aim 1: To assess barriers & facilitators of linkage to HCV care Qualitative study Aim 2: To tailor the existing intervention to create an enhanced care coordination intervention Address the barriers & facilitators identified Use peer mentors Aim 3: To pilot test the feasibility and effectiveness of HCV-ACCELERATE in an RCT

25 Acknowledgments Primary Mentors Alain Litwin, MD, MPH, MS Chinazo Cunningham, MD, MS Other Mentors and Collaborators Ross MacDonald, MD Alison Jordan, LCSW Jody Rich, MD, MPH Julia Arnsten, MD, MPH Moonseong Heo, PhD Alison Karasz, PhD Participants HCV Linkage Study Co-authors Jessie Schwartz, MPH Devin Columbus, MA Ellie Carmody, MD, MPH Ben Eckhardt, MD Funding NIDA (K99DA043011) NIDDK (P30DK41296) Gilead Sciences - Investigator Sponsored Research

26 Questions/Contact:

27 References Beckwith CG, Kurth AE, Bazerman LB et ai. J Public Health (Oxf) Mar;38(1): Hennessey KA et al. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States. J Urban Health.2009 Jan;86(1): Hochstatter KR, Stockman LJ, Holzmacher R et al. The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care. Health Justice Oct 30;5(1):10. Jordan AO, Cohen LR, Harriman G et al. Transitional care coordination in New York City jails: facilitating linkages to care for people with HIV returning home from Rikers Island. AIDS Behav Oct;17 Suppl 2:S Kaeble D, Glaze L. Correctional populations in the United States, Bureau of Justice Statistics NCJ Available at: Schoenbachler BT, Smith BD, Seña AC et al. Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, Public Health Rep May-Jun;131 Suppl 2: Varan AK et al. Hepatitis C seroprevalence among prison incarcerated patients since 2001: still high but declining. Public Health Rep. 2014; 129(2): Wenger PJ, Rottnek F, Parker T, Crippin JS. Assessment of hepatitis C risk factors and infection prevalence in a jail population. Am J Public Health Sep;104(9):

From Jail to Peer Counselor: HIV Educator Training Increases HIV Testing

From Jail to Peer Counselor: HIV Educator Training Increases HIV Testing From Jail to Peer Counselor: HIV Educator Training Increases HIV Testing Skye Ross, LMSW, MPH Alison O Jordan, LCSW Randi Sinnreich, LMSW Allison Dansby, LMSW Presenter Disclosures Skye Dina Ross (1) The

More information

HIV and Incarceration: Dual Epidemics

HIV and Incarceration: Dual Epidemics HIV and Incarceration: Dual Epidemics David A. Wohl, MD Site Leader. UNC AIDS Clinical Trials Unit at Chapel Hill Co-Director of HIV Services for NC Department of Public Safety Take Homes Incarceration

More information

International Network on Hepatitis in Substance Users

International Network on Hepatitis in Substance Users High Rates of Sustained Virological Response in People Who Inject Drugs Treated With Sofosbuvir-Based Regimens Alain H. Litwin, MD, MPH Kim K. Yu, MPH Linda Agyemang, MPH Jordan Wong, RPA Irene J. Soloway,

More information

Alain H. Litwin, M.D., M.P.H.

Alain H. Litwin, M.D., M.P.H. Interventions to Enhance Adherence to IFN-free HCV Therapy Among People Who Inject Drugs Alain H. Litwin, M.D., M.P.H. International Network on Hepatitis in Substance Users Albert Einstein College of Medicine

More information

Beyond the Prison Walls: Relinkage and Retention 2.0

Beyond the Prison Walls: Relinkage and Retention 2.0 Beyond the Prison Walls: Relinkage and Retention 2.0 Mo Wahome, MPH James Ealy, MA Regina Ubaldi-Rosen, CRNP AIDS Care Group 2016 NATIONAL RYAN WHITE CONFERENCE ON HIV CARE & TREATMENT Disclosures Presenters

More information

Chronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA

Chronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA Chronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA Julia H. Arnsten, MD, MPH Professor of Medicine, Epidemiology, and Psychiatry

More information

Short-term Navigation successful at re-engaging patients in care

Short-term Navigation successful at re-engaging patients in care Short-term Navigation successful at re-engaging patients in care IAPAC June 29, 2015 Darpun Sachdev, MD Sharon Pipkin, MPH Susan Scheer, PhD, MPH Stephanie Cohen, MD, MPH Erin Antunez, M.S. San Francisco

More information

Use of an mhealth Intervention to Improve HIV Treatment and Engagement in HIV Care among Recently Incarcerated Persons in Washington, DC

Use of an mhealth Intervention to Improve HIV Treatment and Engagement in HIV Care among Recently Incarcerated Persons in Washington, DC Use of an mhealth Intervention to Improve HIV Treatment and Engagement in HIV Care among Recently Incarcerated Persons in Washington, DC Irene Kuo 1, Tao Liu 2, Rudy Patrick 1, Lauri Bazerman 3, Claudia

More information

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017 Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017 Conflicts of interest Receive

More information

Buprenorphine Treatment at 11 Years: Trends in an Urban Community Health Center. Tiffany Lu, MD AMERSA Conference Washington DC November 4, 2017

Buprenorphine Treatment at 11 Years: Trends in an Urban Community Health Center. Tiffany Lu, MD AMERSA Conference Washington DC November 4, 2017 Buprenorphine Treatment at 11 Years: Trends in an Urban Community Health Center Tiffany Lu, MD AMERSA Conference Washington DC November 4, 2017 Disclosures None Introduction Buprenorphine is an effective

More information

A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail

A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail The Warren Alpert Medical School of Brown University A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail Michelle McKenzie, MPH Bradley Brockmann, JD Nickolas Zaller, PhD Josiah

More information

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation Kenya Outline of the presentation Background: Kenya in Context PMTCT Program progress 2012-2015 Option

More information

NIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2011 April 1.

NIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2011 April 1. NIH Public Access Author Manuscript Published in final edited form as: J Acquir Immune Defic Syndr. 2010 April 1; 53(4): 485 490. doi:10.1097/qai.0b013e3181c997b1. HIV Risk Behavior Before and After HIV

More information

Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population

Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population Neil Bretaña, Lies Boelen, Rowena Bull, Suzy Teutsch, Peter White, Andrew Lloyd, Fabio Luciani on behalf of

More information

Bruce Kreter, PharmD Senior Director, Global HCV Medical Affairs Gilead Sciences, Inc.

Bruce Kreter, PharmD Senior Director, Global HCV Medical Affairs Gilead Sciences, Inc. CDC Foundation & Viral Hepatitis Action Coalition: Summit for the Elimination of Hepatitis B and Hepatitis C as Public Health Threats in the United States Bruce Kreter, PharmD Senior Director, Global HCV

More information

IMPLEMENTING AN HCV PROGRAM IN AN ESTABLISHED ASO DURING THEIR TRANSITION TO COMMUNITY HEALTH

IMPLEMENTING AN HCV PROGRAM IN AN ESTABLISHED ASO DURING THEIR TRANSITION TO COMMUNITY HEALTH IMPLEMENTING AN HCV PROGRAM IN AN ESTABLISHED ASO DURING THEIR TRANSITION TO COMMUNITY HEALTH Amanda Goodpasture HCV Navigator Equitas Health, Columbus, Ohio Maria Brown, CDCA HCV Navigator Equitas Health,

More information

Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations

Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations Robert P. Schwartz, M.D. Rschwartz@friendsresearch.org Friends Research Institute www.friendsresearch.org

More information

Jail Intervention: Transitional Care Coordination (TCC) Office of Epidemiology and Disease Surveillance Southern Nevada Health District

Jail Intervention: Transitional Care Coordination (TCC) Office of Epidemiology and Disease Surveillance Southern Nevada Health District Jail Intervention: Transitional Care Coordination (TCC) Office of Epidemiology and Disease Surveillance Southern Nevada Health District Background For Today Transitional Care Coordination (TCC) Model Preliminary

More information

Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus

Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus Determinants of Response to Pegylated Interferon and Ribavirin for Acute Hepatitis C Infection in Patients with Human Immunodeficiency Virus Leah Burke, M.D. 1, Daniel Fierer, M.D. 2, David Cassagnol,

More information

Infectious Disease and the Opioid Epidemic: Correctional Health

Infectious Disease and the Opioid Epidemic: Correctional Health Infectious Disease and the Opioid Epidemic: Correctional Health Josiah Jody Rich, MD, MPH Professor of Medicine and Epidemiology, Brown University Director of the Center for Prisoner Health and Human Rights,

More information

I know it because I live it An In-clinic peer mentorship scheme to improve outcomes in adolescents living with HIV

I know it because I live it An In-clinic peer mentorship scheme to improve outcomes in adolescents living with HIV I know it because I live it An In-clinic peer mentorship scheme to improve outcomes in adolescents living with HIV Theme: Working with Patients and Communities Alison Barnes, MSN MPH HIV in the UK Over

More information

Hepatitis C Testing and Linkage to Care

Hepatitis C Testing and Linkage to Care Hepatitis C Testing and Linkage to Care Arlene C. Seña, MD, MPH Medical and Laboratory Director, Durham County Department of Public Health Associate Professor, UNC-Chapel Hill, Division of Infectious Diseases

More information

National Conference of State Legislators

National Conference of State Legislators National Conference of State Legislators Mark W. Parrino, M.P.A. Monday, July 20, 2009 Philadelphia, PA Medication Assisted Treatment for Opiate Addiction In the Criminal Justice System Updated August

More information

Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) Professor Andrew Lloyd Wednesday 7 th October 2015

Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) Professor Andrew Lloyd Wednesday 7 th October 2015 Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) Professor Andrew Lloyd Wednesday 7 th October 2015 Australian prison population 30,775 5% 34 92% Total population Increase from 2012 Median

More information

Effective Substance Abuse Treatment in The Criminal Justice System

Effective Substance Abuse Treatment in The Criminal Justice System 1 Effective Substance Abuse Treatment in The Criminal Justice System Redonna K. Chandler, Ph.D. Acting Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse,

More information

Strategic Peer-Enhanced Care and Treatment Retention Model (SPECTRuM) Initiative. Intervention Protocol #2

Strategic Peer-Enhanced Care and Treatment Retention Model (SPECTRuM) Initiative. Intervention Protocol #2 MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH BUREAU OF INFECTIOUS DISEASE AND LABORATORY SCIENCES HIV/AIDS AND STD SURVEILLANCE PROGRAM AND OFFICE OF HIV/AIDS Strategic Peer-Enhanced Care and Treatment Retention

More information

Data: Access, Sources, and Systems

Data: Access, Sources, and Systems EXEMPLARY INTEGRATED HIV PREVENTION AND CARE PLAN SECTIONS Data: Access, Sources, and Systems REGION PLAN TYPE JURISDICTIONS HIV PREVALENCE Midwest Integrated state-only prevention and care plan State

More information

Community Reentry. MLCHC Conference, May 7, 2013

Community Reentry. MLCHC Conference, May 7, 2013 Community Reentry Warren J. Ferguson, MD Professor and Vice Chair Department of Family Medicine and Community Health University of Massachusetts Medical School MLCHC Conference, May 7, 2013 Objectives

More information

Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018

Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018 Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018 2 Project SUCCEED Team Natalie Octave, MPH, CHES Project

More information

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap

More information

Hepatitis C Care Cascade. At the Dallas County Jail Caroline Abe; Merilyne Aguwa, LVN; Esmaeil Porsa, MD, MPH; Ank E Nijhawan, MD, MPH, MSCS

Hepatitis C Care Cascade. At the Dallas County Jail Caroline Abe; Merilyne Aguwa, LVN; Esmaeil Porsa, MD, MPH; Ank E Nijhawan, MD, MPH, MSCS 1 Hepatitis C Care Cascade At the Dallas County Jail Caroline Abe; Merilyne Aguwa, LVN; Esmaeil Porsa, MD, MPH; Ank E Nijhawan, MD, MPH, MSCS Background Hepatitis C Virus (HCV) prevalence is up to 10 times

More information

Project Connections Buprenorphine Program

Project Connections Buprenorphine Program Project Connections Buprenorphine Program Program & Client Summary 2010-2017 Behavioral Health Leadership Institute November 2017 November 2017 1 Table of Contents I. Overview of the Project Connections

More information

Aging and mortality in the state prison population

Aging and mortality in the state prison population U.S. Department of Justice Office of Justice Programs Presented by E. Ann Carson and Margaret Noonan Statisticians Corrections Unit Aging and mortality in the state prison population BUREAU OF JUSTICE

More information

Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy F

Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy F Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy Fitzgerald) 93% of participants in the Care Coach program

More information

Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model

Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model Catelyn Coyle MPH, MEd Public Health National Symposium June 2014 Outline Background Description of model

More information

Beckwith CG. et al. (2015) A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health (Oxf), 1-8.

Beckwith CG. et al. (2015) A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health (Oxf), 1-8. Criteria Grid Hepatitis C Research Studies, Tools, and Surveillance Systems Best Practice/Intervention: Beckwith CG. et al. (2015) A pilot study of rapid hepatitis C virus testing in the Rhode Island Department

More information

BIOGRAPHICAL SKETCH. NAME: Chinazo O. Cunningham, MD, MS. era COMMONS USER NAME (credential, e.g., agency login): CHINAZO1

BIOGRAPHICAL SKETCH. NAME: Chinazo O. Cunningham, MD, MS. era COMMONS USER NAME (credential, e.g., agency login): CHINAZO1 BIOGRAPHICAL SKETCH OMB No. 0925-0001/0002 (Rev. 08/12 Approved Through 8/31/2015) NAME: Chinazo O. Cunningham, MD, MS era COMMONS USER NAME (credential, e.g., agency login): CHINAZO1 POSITION TITLE: Associate

More information

Targeted Outreach & Other Strategies for Increasing HCV Testing

Targeted Outreach & Other Strategies for Increasing HCV Testing Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department

More information

OPIATES IN PRISON. Jeffrey C. Fetter, MD

OPIATES IN PRISON. Jeffrey C. Fetter, MD OPIATES IN PRISON Jeffrey C. Fetter, MD Agenda Opioids in the Correctional Environment MAT and Corrections Substance Abuse Treatment in NH DOC Suboxone Suboxone: Contraband Suboxone Contraband Scale of

More information

State of the Art for ART for Prevention. Wafaa El-Sadr, MD, MPH ICAP-Columbia University

State of the Art for ART for Prevention. Wafaa El-Sadr, MD, MPH ICAP-Columbia University State of the Art for ART for Prevention Wafaa El-Sadr, MD, MPH ICAP-Columbia University Millions Global Scale-Up of HIV Treatment 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 End of 2002 End of 2003 End of 2004

More information

Strategies to enhance HCV testing, linkage to care and treatment

Strategies to enhance HCV testing, linkage to care and treatment Strategies to enhance HCV testing, linkage to care and treatment STACEY B. TROOSKIN M D PHD DIREC TOR OF VIRAL HEPAT I T IS PROGRAMS PHILADELPHIA FIGHT COMMUNITY HEA LT H CENTERS PHILADELPHIA, PA Disclosures

More information

Syndemics: Part 2. July 19, Ryan P. Westergaard, MD, PhD, MPH. Division of Infectious Diseases

Syndemics: Part 2. July 19, Ryan P. Westergaard, MD, PhD, MPH. Division of Infectious Diseases Syndemics: Part 2 What Infectious Disease Providers Need to Know About Addiction Treatment July 19, 2018 Ryan P. Westergaard, MD, PhD, MPH Division of Infectious Diseases University of Wisconsin School

More information

Using the Learning Collaborative Model to Craft and Test Systems-Level Linkage to Care Interventions

Using the Learning Collaborative Model to Craft and Test Systems-Level Linkage to Care Interventions Using the Learning Collaborative Model to Craft and Test Systems-Level Linkage to Care Interventions Lori DeLorenzo, RN, MSN Sophie Lewis Steven Sawicki, MHSA Anne Rhodes, PhD Acknowledgement/Disclosure

More information

All four components must be present, but Part A funds to be used for HIV testing only as necessary to supplement, not supplant, existing funding.

All four components must be present, but Part A funds to be used for HIV testing only as necessary to supplement, not supplant, existing funding. EARLY INTERVENTION SERVICES I. DEFINITION OF SERVICE Support of Early Intervention Services (EIS) that include identification of individuals at points of entry and access to services and provision of:

More information

Improving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership

Improving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership Improving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership Lena Asmar, MSW, LICSW Director, Veteran 360 Behavioral Health Programs, New England Center and Home for Veterans

More information

Hepatitis C Elimination Program Georgia

Hepatitis C Elimination Program Georgia Hepatitis C Elimination Program Georgia Maia Butsashvili, MD, MS, PhD Health Research Union (HRU)/Clinic NEOLAB National HCV Committee International School of Public Health High prevalence of HCV in Georgia

More information

HCV Treatment in Injection Drug Users

HCV Treatment in Injection Drug Users Project ECHO HCV Collaborative HCV Treatment in Injection Drug Users Jacob Kesner, PharmD Antimicrobial Stewardship / Infectious Diseases Pharmacist Lovelace Medical Center September 27 th, 2017 Presentation

More information

Public-Private Collaboration to Re-engage Out-of-Care Persons into HIV Care

Public-Private Collaboration to Re-engage Out-of-Care Persons into HIV Care Public-Private Collaboration to Re-engage Out-of-Care Persons into HIV Care Chi-Chi Udeagu, MPH Jamie Huang, MPH Lil Eason Leonard Pickett New York City Department of Health and Mental Hygiene Adherence

More information

Community-based sanctions

Community-based sanctions Community-based sanctions... community-based sanctions used as alternatives to incarceration are a good investment in public safety. Compared with incarceration, they do not result in higher rates of criminal

More information

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE Site C Youth clinic HIV care pathway DAY 1 Test HIV + PIMA point of care CD4 count in in 3-5 days initiation + in session 3 session 4 1 month Youth Club

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.

More information

Placing the United States on the Path Toward the Elimination of Hepatitis C as a Public Health Threat

Placing the United States on the Path Toward the Elimination of Hepatitis C as a Public Health Threat Placing the United States on the Path Toward the Elimination of Hepatitis C as a Public Health Threat John W. Ward, M.D Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD &

More information

Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial.

Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial. Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial. Yvette Calderon, MD MS 1,2, Ethan Cowan, MD MS 1,2, Rajesh Verma, MD 1, Mark Iscoe

More information

Surveillance-Based Re-linkage to HIV Care: The King County Experience

Surveillance-Based Re-linkage to HIV Care: The King County Experience University of Washington Public Health Capacity Building Center Surveillance-Based Re-linkage to HIV Care: The King County Experience Elizabeth Barash, MPH PHSKC HIV/STD Program Mark Fleming and Angela

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result

More information

Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination for Jail Inmates

Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination for Jail Inmates Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 2007 Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination

More information

High Yield and Feasibility of Baby Boomer Birth Cohort HCV Screening in Two Urban, Academic Emergency Departments

High Yield and Feasibility of Baby Boomer Birth Cohort HCV Screening in Two Urban, Academic Emergency Departments High Yield and Feasibility of Baby Boomer Birth Cohort HCV Screening in Two Urban, Academic Emergency Departments James W Galbraith, MD 1 ; Jordan Morgan, MPH 1 ; Joel Rodgers, MPH 1 ; Ricardo Franco,

More information

LUCAS COUNTY TASC, INC. OUTCOME ANALYSIS

LUCAS COUNTY TASC, INC. OUTCOME ANALYSIS LUCAS COUNTY TASC, INC. OUTCOME ANALYSIS Research and Report Completed on 8/13/02 by Dr. Lois Ventura -1- Introduction -2- Toledo/Lucas County TASC The mission of Toledo/Lucas County Treatment Alternatives

More information

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Rate per, Types of Viral Hepatitis A E B D C Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Source of virus Feces Feces Blood/bloodderived body fluids

More information

Creating a Safety Net for HIV Exposed Infants in Illinois

Creating a Safety Net for HIV Exposed Infants in Illinois Creating a Safety Net for HIV Exposed Infants in Illinois Perinatal HIV Elimination Project Anne Statton BA, Laurie Ayala MPH, Yolanda Olszewski MS MPH National HIV Prevention Conference December 3, 2007

More information

CalOMS Discharge Form Instructions

CalOMS Discharge Form Instructions Form Instructions REQUIRED FORM: The Discharge form is a required document in the client file WHEN: This form will be created at the end of the client s treatment episode and completed in SanWITS by the

More information

MeckFUSE: Diversion Works Better the Second Time Around

MeckFUSE: Diversion Works Better the Second Time Around MeckFUSE: Diversion Works Better the Second Time Around Charlotte, Mecklenburg County, North Carolina SESSION PRESENTERS FOR MARCH 28 AT 10:30 CAROLINE CHAMBRE, HOUSINGWORKS DIRECTOR Urban Ministry Center

More information

Behind the Cascade: Analyzing Spatial Patterns Along the HIV Care Continuum

Behind the Cascade: Analyzing Spatial Patterns Along the HIV Care Continuum Behind the Cascade: Analyzing Spatial Patterns Along the HIV Care Continuum Kathleen Brady 1,2, M. Eberhart 1, A. Hillier 2, C. Voytek 2, M. Blank 2, I. Frank 2, D. Metzger, 2 B. Yehia 2 1 Philadelphia

More information

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD Objectives Provide an overview of harm reduction by defining shared language and key terms. Collaboratively

More information

Barriers to Management of HCV: Treating People Who Use Drugs. May 9, 2015

Barriers to Management of HCV: Treating People Who Use Drugs. May 9, 2015 Barriers to Management of HCV: Treating People Who Use Drugs Alain Litwin, MD, MPH Albert Einstein College of Medicine Montefiore Medical Center May 9, 2015 Disclosures Gilead Pharmaceuticals Janssen Pharmaceuticals

More information

Assessing Clinic-Level Factors that Impact Viral Load Suppression

Assessing Clinic-Level Factors that Impact Viral Load Suppression Assessing Clinic-Level Factors that Impact Viral Load Suppression Bisrat Abraham, MD, MPH Carly Skinner, FNP-BC Erica Crittendon, MS Muhammad Daud, MD Background Viral load suppression is one of the prime

More information

ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece

ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece IVHEM, 6-7 December 2018 ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece Vana Sypsa Department of Hygiene, Epidemiology and Medical Statistics Medical School,

More information

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Note: Staff who work in case management programs should attend the AIDS Institute training, Addressing Prevention in HIV Case Management. Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting

More information

Lifetime Benefits and Costs of Diverting Substance Abusing Offenders from State Prison

Lifetime Benefits and Costs of Diverting Substance Abusing Offenders from State Prison Lifetime Benefits and Costs of Diverting Substance Abusing Offenders from State Prison Presented by Gary A. Zarkin, Alexander J. Cowell, Katherine A. Hicks, Laura J. Dunlap, Steven Belenko, Michael J.

More information

HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity

HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity Anne C. Spaulding 1 *, Ryan M. Seals 1, Matthew J. Page

More information

Implementing and Evaluating a Peer Enhanced Intervention:

Implementing and Evaluating a Peer Enhanced Intervention: Implementing and Evaluating a Peer Enhanced Intervention: Results from a randomized control trial Jane Fox, MPH, Boston University School of Public Health Janet Goldberg, MPH, PATH Center, The Brooklyn

More information

Study of Recidivism, Race, Gender, and Length of Stay

Study of Recidivism, Race, Gender, and Length of Stay Study of Recidivism, Race, Gender, and Length of Stay Releases from the Dutchess County Jail December 2011 - October 2012 November 12, 2013 1 As part of its ongoing commitment to evidence-based criminal

More information

The Heterosexual HIV Epidemic in Chicago: Insights into the Social Determinants of HIV

The Heterosexual HIV Epidemic in Chicago: Insights into the Social Determinants of HIV The Heterosexual HIV Epidemic in Chicago: Insights into the Social Determinants of HIV Nikhil Prachand, MPH Board of Health Meeting January 19, 2011 STI/HIV/AIDS Division Today s Presentation Epidemiology

More information

Miami-Dade County Getting to Zero HIV/AIDS Task Force Implementation Report

Miami-Dade County Getting to Zero HIV/AIDS Task Force Implementation Report 1 Miami-Dade County Getting to Zero HIV/AIDS Task Force Implementation Report Make HIV History! Know the Facts Get Tested Get Treated 2017-2018 7/9/2018 1 2 7/9/2018 2 3 Progress on the Getting to Zero

More information

Hepatitis B Virus and the Opioid Crisis

Hepatitis B Virus and the Opioid Crisis Hepatitis B Virus and the Opioid Crisis Alice Asher, RN, Ph.D. Epidemiology and Surveillance Branch Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers

More information

HCV screening in Australia What we do now, and what we hope to do in future? Professor Gregory Dore

HCV screening in Australia What we do now, and what we hope to do in future? Professor Gregory Dore HCV screening in Australia What we do now, and what we hope to do in future? Professor Gregory Dore Disclosures Research grants, travel support, and honoraria: AbbVie, Gilead, Merck HCV screening in Australia

More information

Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania

Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania COUNTRY: Tanzania Tanzania has successfully implemented the standard

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Data to Care: Improving Health Across the HIV Care Continuum in Colorado

Data to Care: Improving Health Across the HIV Care Continuum in Colorado Data to Care: Improving Health Across the HIV Care Continuum in Colorado NASTAD Technical Assistance Meeting July 31, 2015 Maria Chaidez Statewide Linkage to Care Coordinator Quick Overview of CO As of

More information

Returning HIV-exposed infants to care in Lilongwe, Malawi

Returning HIV-exposed infants to care in Lilongwe, Malawi Returning HIV-exposed infants to care in Lilongwe, Malawi Results from a pilot integrating infant defaulter tracing into the Malawi Option B+ programme Esmie Kamanga, Grace Banda, Innocent Mofolo, Gertrude

More information

Service Model: For Non-Clinical and Clinical Settings: HIV Testing. Agencies may employ evidence-based strategies, including the social network

Service Model: For Non-Clinical and Clinical Settings: HIV Testing. Agencies may employ evidence-based strategies, including the social network Goals: Objectives: 1) Provide services focusing on early diagnosis, engagement, linkage, and retention of newly diagnosed PLWHA into primary care, thereby serving to improve CD4 count, suppress viral load,

More information

Oriana House, Inc. Substance Abuse Treatment. Community Corrections. Reentry Services. Drug & Alcohol Testing. Committed to providing programming

Oriana House, Inc. Substance Abuse Treatment. Community Corrections. Reentry Services. Drug & Alcohol Testing. Committed to providing programming Oriana House, Inc. Committed to providing programming that changes lives and contributes to safer communities. Services include: Substance Abuse Community Corrections Reentry Services Headquartered in

More information

HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity

HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity HIV/AIDS among Inmates of and Releasees from US Correctional Facilities, 2006: Declining Share of Epidemic but Persistent Public Health Opportunity Anne C Spaulding, Emory University Ryan M. Seals, Emory

More information

Supervised Treatment Interruption (STI) in an Urban HIV Clinical Practice: A Prospective Analysis.

Supervised Treatment Interruption (STI) in an Urban HIV Clinical Practice: A Prospective Analysis. Supervised Treatment Interruption (STI) in an Urban HIV Clinical Practice: A Prospective Analysis. J.L. YOZVIAK 1, P. KOUVATSOS 2, R.E. DOERFLER 3, W.C. WOODWARD 3 1 Philadelphia College of Osteopathic

More information

Positive Living Conference

Positive Living Conference Positive Living Conference Ft. Walton Beach, Thomas Liberti Chief, Bureau of HIV/AIDS Department of Health March 11, 2011 Tallahassee, 1 The Epidemic in, 2010 60% White Population: 18.8 million (4 th 16%

More information

Alcohol and Drug Abuse Services Client Demographics and Treatment Outcomes

Alcohol and Drug Abuse Services Client Demographics and Treatment Outcomes and Drug Abuse Services Client Demographics and Treatment Outcomes Based on California Outcomes Measurement System - Treatment (26 28) Prepared by: Curtis J. Condon, PhD Alaka Nafday, MS, MSc Samantha

More information

Re-linkage and Retention in Care of HIV-diagnosed Persons presumed to be Out-of-Care Based on New York City Surveillance Data

Re-linkage and Retention in Care of HIV-diagnosed Persons presumed to be Out-of-Care Based on New York City Surveillance Data Re-linkage and Retention in Care of HIV-diagnosed Persons presumed to be Out-of-Care Based on New York City Surveillance Data Chi-Chi N. Udeagu, MPH Epidemiology and Field Services Program New York City

More information

Health Department-assisted HIV Partner and Linkage Care Services

Health Department-assisted HIV Partner and Linkage Care Services Health Department-assisted HIV Partner and Linkage Care Services Chi-Chi N. Udeagu, MPH HIV Epidemiology and Field Services program Bureau of HIV/AIDS Prevention and Control New York City Department of

More information

WORKING SESSION: CREATING AN HCV CURE CASCADE

WORKING SESSION: CREATING AN HCV CURE CASCADE WORKING SESSION: CREATING AN HCV CURE CASCADE Danica Kuncio, MPH Viral Hepatitis Program Manager Philadelphia Department of Public Health NASTAD National Hepatitis Technical Assistance Meeting Washington,

More information

HIV/AIDS Medical Case Management Acuity Assessment Massachusetts Department of Public Health Boston Public Health Commission

HIV/AIDS Medical Case Management Acuity Assessment Massachusetts Department of Public Health Boston Public Health Commission Area of Functioning: HIV Care Adherence Dates of last 2 HIV Appointments: dd/mm/yyyy dd/mm/yyyy Has missed 2 or more consecutive HIV medical appointments in the last 6 months Has missed 1 or 2 (non-consecutive)

More information

Closing the Loop in Treating Opioid Addiction:

Closing the Loop in Treating Opioid Addiction: Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:

More information

Using a Data to Care Approach to Eliminate Hepatitis C in People Living with HIV in NYC

Using a Data to Care Approach to Eliminate Hepatitis C in People Living with HIV in NYC Project SUCCEED: Using a Data to Care Approach to Eliminate Hepatitis C in People Living with HIV in NYC Nirah Johnson, LCSW NYC Department of Health Viral Hepatitis Program Data to Care CDC-developed

More information

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS Baker D 1,2, McMurchie M 1, Rodgers C 1, Farr V 1, Williams M 1 1 East Sydney Doctors, 2 Australasian Society for HIV Medicine 1 Disclosures Advisory

More information

Extended-Release Naltrexone for Opioid Relapse Prevention Among Community Criminal Justice Participants

Extended-Release Naltrexone for Opioid Relapse Prevention Among Community Criminal Justice Participants Extended-Release Naltrexone for Opioid Relapse Prevention Among Community Criminal Justice Participants JD Lee 1, PD Friedmann 2, TW Kinlock 3, EV Nunes 4, CP O Brien 5 1. New York University School of

More information

Medical Conditions, Mental Health Problems, Disabilities, and Mortality Among Jail Inmates American Jail Association

Medical Conditions, Mental Health Problems, Disabilities, and Mortality Among Jail Inmates American Jail Association Medical Conditions, Mental Health Problems, Disabilities, and Mortality Among Jail Inmates American Jail Association Posted in: Articles, Magazine May 03 at 8:48 am Jails are primarily local, county, and

More information

Health and Justice. Hochstatter et al. Health and Justice (2017) 5:10 DOI /s

Health and Justice. Hochstatter et al. Health and Justice (2017) 5:10 DOI /s Hochstatter et al. Health and Justice (2017) 5:10 DOI 10.1186/s40352-017-0055-0 Health and Justice RESEARCH ARTICLE Open Access The continuum of hepatitis C care for criminal justice involved adults in

More information

Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release

Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release Apryl L. Herron, MPH Clackamas County Public Health Division Kristen Watson, CADC II, QMHA Clackamas

More information

Outline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs

Outline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs Joanna Buffington, MD, MPH Division of Viral Hepatitis National Immunization

More information

D R. T E R R I T I M B E R L A K E J I L L M A Y S

D R. T E R R I T I M B E R L A K E J I L L M A Y S DBHDD/ GDC/ DCS Forensic Peer Mentor Collaboration D R. T E R R I T I M B E R L A K E J I L L M A Y S D B H D D O F F I C E O F A D U L T M E N T A L H E A L T H D I V I S I O N O F B E H A V I O R A L

More information

Barriers and facilitators to routine HIV testing among Massachusetts community health centers:

Barriers and facilitators to routine HIV testing among Massachusetts community health centers: Barriers and facilitators to routine HIV testing among Massachusetts community health centers: An example of Community-Based Participatory Research Carey V. Johnson, ScM Study Coordinator The Fenway Institute

More information